Moreira, T.d.S.; Silva, A.D.O.; Vasconcelos, B.R.F.; Santos, E.d.S.; de Sousa, A.C.C.; de Freitas, J.V.B.; de Oliveira, Y.S.; Vidal, L.M.T.; Ribeiro, F.d.O.S.; de Araújo, A.R.;
et al. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics 2023, 15, 915.
https://doi.org/10.3390/pharmaceutics15030915
AMA Style
Moreira TdS, Silva ADO, Vasconcelos BRF, Santos EdS, de Sousa ACC, de Freitas JVB, de Oliveira YS, Vidal LMT, Ribeiro FdOS, de Araújo AR,
et al. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics. 2023; 15(3):915.
https://doi.org/10.3390/pharmaceutics15030915
Chicago/Turabian Style
Moreira, Thais da Silva, Alan Denis Olivindo Silva, Bianca Rodrigues Farias Vasconcelos, Elias da Silva Santos, Ana Carolina Cruz de Sousa, João Vito Barroso de Freitas, Yara Santiago de Oliveira, Laura Maria Teodorio Vidal, Fábio de Oliveira Silva Ribeiro, Alyne Rodrigues de Araújo,
and et al. 2023. "DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells" Pharmaceutics 15, no. 3: 915.
https://doi.org/10.3390/pharmaceutics15030915
APA Style
Moreira, T. d. S., Silva, A. D. O., Vasconcelos, B. R. F., Santos, E. d. S., de Sousa, A. C. C., de Freitas, J. V. B., de Oliveira, Y. S., Vidal, L. M. T., Ribeiro, F. d. O. S., de Araújo, A. R., Vieira Neto, J. d. B., Pessoa, C. d. Ó., Petrilli, R., & Eloy, J. O.
(2023). DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics, 15(3), 915.
https://doi.org/10.3390/pharmaceutics15030915
